摘要
目的探讨2型糖尿病(T2DM)合并心力衰竭(HF)患者红细胞分布宽度(RDW)和胰岛素抵抗指数(HOMA-IR)及与预后的关系。方法选择2018年1月至2021年1月我院收治的88例T2DM合并HF患者,根据患者预后情况分为死亡组和生存组,检测患者RDW及HOMA-IR,分析与患者预后的关系。结果死亡组HOMA-IR、RDW高于对照组(P<0.05)。Logistic回归分析显示HOMA-IR、RDW为影响T2DM合并HF患者预后的危险因素(P<0.05)。联合检测评估患者预后的效能高于HOMA-IR、RDW单独检测(P<0.05)。结论HOMA-IR与RDW为T2DM合并HF患者预后死亡的危险因素,联合检测可提高评估患者预后的价值。
Objective To explore the correlation between red cell distribution width(RDW),insulin resistance index(HOMA-IR)and prognosis in patients with type 2 diabetes mellitus(T2DM)complicated with heart failure(HF).Methods 88 T2DM patients with HF admitted to our hospital from January 2018 to January 2021 were selected and divided into death group and survival group according to the prognosis.The RDW and HOMA-IR were detected,and the correlation with the prognosis was analyzed.Results The HOMA-IR and RDW of the death group were higher than those of the control group(P<0.05).Logistic regression analysis showed that HOMA-IR and RDW were risk factors affecting the prognosis of T2DM patients with HF(P<0.05).The efficacy of combined detection in evaluating the prognosis of patients was higher than that of HOMA-IR and RDW alone(P<0.05).Conclusions HOMA-IR and RDW are the risk factors of death prognosis in T2DM patients with HF.Combined detection can improve the value of evaluating the prognosis of patients.
作者
赵艳珍
吴倩倩
ZHAO Yanzhen;WU Qianqian(Clinical Laboratory,Xiangcheng Hospital of Traditional Chinese Medicine,Zhoukou 466200,China)
出处
《临床医学工程》
2022年第9期1213-1214,共2页
Clinical Medicine & Engineering
基金
河南省医学科技攻关计划联合共建项目(LHGJ20191506)。